LeeSRosenMD
Hematology • Santa Monica, CAMyeloproliferative Disorder Hematology-Oncology
Professor, Medicine, University of California Los Angeles David Geffen SOM
Dr. Rosen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2020 Santa Monica Blvd
Ste 510
Santa Monica, CA 90404Phone+1 310-633-8400Fax+1 310-633-8419
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Hematology and Medical Oncology, 1993 - 1996- UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Internal Medicine, 1990 - 1993
Baylor College of MedicineClass of 1990
Certifications & Licensure
CA State Medical License 1991 - 2027
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Fellow (FACP) American College of Physicians, 2011
- Super Doctor SuperDoctors.com
Clinical Trials
- Tocladesine in Treating Patients With Recurrent or Progressive Metastatic Colorectal Cancer Start of enrollment: 2001 Apr 01
- Combination Chemotherapy With or Without SU5416 in Treating Patients With Metastatic Colorectal Cancer Start of enrollment: 2000 Dec 01
- Paclitaxel, Folic Acid, and Lometrexol in Treating Patients With Locally Advanced or Metastatic Solid Tumors Start of enrollment: 2001 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- 3 citationsFirst-in-human clinical outcomes with NG-350A, an anti-CD40 expressing tumor-selective vector designed to remodel immunosuppressive tumor microenvironments.Aung Naing, Danny Khalil, Oliver Rosen, D Ross Camidge, Tom Lillie
Journal for Immunotherapy of Cancer. 2024-10-15 - Correction to: A tumor-selective adenoviral vector platform induces transient antiphospholipid antibodies, without increased risk of thrombosis, in phase 1 clinical st...Danny N Khalil, Isabel Prieto González-Albo, Lee Rosen, Tom Lillie, Andrea Stacey
Investigational New Drugs. 2023-06-01 - 16 citationsSafety and efficacy of the tumor-selective adenovirus enadenotucirev, in combination with nivolumab, in patients with advanced/metastatic epithelial cancer: a phase I ...Marwan Fakih, Wael Harb, Daruka Mahadevan, Hani Babiker, Jordan Berlin
Journal for Immunotherapy of Cancer. 2023-04-01
Professional Memberships
- Fellow
- Member
- Member
- Member
Other Languages
- Hebrew, Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
